SMOT - ETF AI Analysis

Top Page

VanEck Morningstar SMID Moat ETF (SMOT)

Rating:68Neutral

Price Target:―

The VanEck Morningstar SMID Moat ETF (SMOT) has a solid overall rating, reflecting a mix of strong performers and some weaker holdings. Notable contributors include Expedia, which benefits from robust financial health and strategic initiatives, and Royalty Pharma, which stands out for its strong financial performance and growth potential. However, holdings like Chart Industries, with concerns around profitability and overvaluation, may weigh on the fund's overall score. A key risk for this ETF is its exposure to stocks with high valuations, which could lead to volatility in certain market conditions.

Positive Factors

Strong Top Holdings

Several of the ETF's largest positions, like Ionis Pharmaceuticals and Etsy, have shown strong year-to-date performance, supporting overall returns.

Sector Diversification

The fund is spread across multiple sectors, including Consumer Cyclical, Technology, and Industrials, reducing reliance on any single industry.

Reasonable Expense Ratio

The ETF has a moderate expense ratio compared to actively managed funds, helping investors keep more of their returns.

Negative Factors

High Geographic Concentration

With nearly all assets focused on U.S. companies, the ETF lacks meaningful global diversification.

Mixed Short-Term Performance

Recent one-month and three-month returns have been modest or slightly negative, indicating short-term volatility.

Small Asset Base

The fund's relatively low assets under management may limit liquidity and scalability compared to larger ETFs.

SMOT vs. SPDR S&P 500 ETF (SPY)

AUM361.34M

RegionNorth America

Expense Ratio0.49%

Beta0.91

IssuerVanEck

Inception DateOct 04, 2022

Dividend YieldN/A

Asset ClassEquity

Index TrackedMorningstar US Small-Mid Cap Moat Focus

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume26,942

30 Day Avg. Volume33,476

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

42.45

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering106

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

SMOT Summary

The VanEck Morningstar SMID Moat ETF (Ticker: SMOT) is an investment fund that focuses on small and mid-sized U.S. companies with strong competitive advantages, or 'moats,' that help them stand out in their industries. It follows the Morningstar US Small-Mid Cap Moat Focus index, which selects businesses with durable business models and growth potential. Some of its top holdings include well-known companies like Etsy and Expedia. Investors might consider SMOT for portfolio diversification and exposure to innovative, smaller companies that could grow over time. However, since it focuses on smaller firms, its performance can be more volatile compared to funds that invest in larger, more stable companies.

How much will it cost me?The VanEck Morningstar SMID Moat ETF (Ticker: SMOT) has an expense ratio of 0.49%, meaning you’ll pay $4.90 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed, focusing on identifying companies with strong competitive advantages or 'moats.'

What would affect this ETF?The VanEck Morningstar SMID Moat ETF could benefit from economic growth and innovation in sectors like technology and consumer cyclical, which make up a significant portion of its holdings. However, it may face challenges if interest rates rise, as smaller companies often struggle with higher borrowing costs, or if economic uncertainty impacts consumer spending. Its focus on U.S. small and mid-cap stocks provides growth potential but also exposes it to volatility compared to large-cap investments.

SMOT Top 10 Holdings

The VanEck Morningstar SMID Moat ETF is leaning heavily into consumer cyclical and technology sectors, with names like Expedia and Cognizant helping drive recent gains thanks to strong earnings and strategic growth initiatives. Ionis Pharmaceuticals is also rising steadily, buoyed by successful product launches despite lingering profitability concerns. On the flip side, Wesco International and Portland GE have shown mixed performance, with valuation and leverage issues holding them back. With its focus on U.S. small and mid-cap stocks, the fund offers a dynamic mix of innovation and resilience, though sector concentration could amplify volatility.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
ALB	Albemarle	1.94%	$7.02M	$17.11B	63.02%	58 Neutral
HII	Huntington Ingalls	1.60%	$5.77M	$13.87B	84.20%	69 Neutral
CCL	Carnival	1.51%	$5.44M	$42.21B	22.76%	78 Outperform
ABNB	Airbnb	1.50%	$5.42M	$84.30B	1.81%	71 Outperform
PCAR	Paccar	1.46%	$5.29M	$59.25B	6.22%	74 Outperform
JKHY	Jack Henry & Associates	1.45%	$5.25M	$13.41B	4.66%	77 Outperform
NDSN	Nordson	1.43%	$5.17M	$13.59B	13.98%	79 Outperform
POR	Portland GE	1.42%	$5.14M	$5.34B	8.20%	70 Outperform
RPRX	Royalty Pharma	1.42%	$5.13M	$22.43B	53.90%	79 Outperform
GEHC	GE Healthcare Technologies Inc	1.42%	$5.12M	$38.24B	5.88%	78 Outperform

SMOT Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

35.64

Positive

100DMA

35.60

Positive

200DMA

34.27

Positive

Market Momentum

MACD

0.29

Negative

RSI

59.59

Neutral

STOCH

15.65

Positive

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SMOT, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 36.16, equal to the 50-day MA of 35.64, and equal to the 200-day MA of 34.27, indicating a bullish trend. The MACD of 0.29 indicates Negative momentum. The RSI at 59.59 is Neutral, neither overbought nor oversold. The STOCH value of 15.65 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SMOT.

SMOT Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
SMOT	―	―	$361.34M	0.49%	―
RSMC	―	―	$715.66M	0.75%	―
MSSM	―	―	$678.04M	0.57%	―
ISMD	―	―	$233.36M	0.57%	―
NBSM	―	―	$199.22M	0.65%	―
SMIZ	―	―	$168.53M	0.56%	―

Performance Comparison

SMOT

VanEck Morningstar SMID Moat ETF

36.54

1.90

5.48%

RSMC

Rockefeller U.S. Small-Mid Cap ETF

―

MSSM

Morgan Stanley Pathway Small-Mid Cap Equity ETF

―

ISMD

Inspire Small/Mid Cap Impact ETF

―

NBSM

Neuberger Berman Small-Mid Cap ETF

―

SMIZ

Zacks Small/Mid Cap ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents